Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway.

导出 OA

翻译打印收藏纠错

作者： Zhiying,Guo ^[1] ; Ming,Zhao ^[1] ; Erin W,Howard ^[1] ; Qingxia,Zhao ^[1] ; Amanda B,Parris ^[1] ; Zhikun,Ma ^[1] ; Xiaohe,Yang ^[1]

作者单位： Julius L. Chambers Biomedical/Biotechnology Research Institute, Department of Biological and Biomedical Sciences, North Carolina Central University, Kannapolis, North Carolina, USA. ^[1]

关键词 MMTV-ErbB2 transgenic mice breast cancer epithelial-mesenchymal transition insulin-like growth factor 1 receptor phenformin

DOI 10.18632/oncotarget.19466

PMID 28947975

发布时间 2023-08-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览12

Oncotarget

2017年8卷36期

60342-60357页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway.

Oncotarget

相似文献

Oncotarget

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway.

Oncotarget

相似文献

Oncotarget

相关期刊

检索历史清除